Security key
48669G105
KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)
CUSIP: 48669G105
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / American Depositary Shares
- Shares outstanding
- 11,425,388
- Total 13F shares
- 4,883,338
- Share change
- +4,641,995
- Total reported value
- $2,151,708
- Price per share
- $0.44
- Number of holders
- 17
- Value change
- +$2,045,684
- Number of buys
- 11
- Number of sells
- 3
Report period
Q4 2023
Institutions
17
Top holders
10
KZIA full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
KAZIA THERAPEUTICS LTD SEC filings
KAZIA THERAPEUTICS LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48669G105
Recent filing periods:
Top shareholders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
1.7%
|
189,950
|
$189,038 | — | 30 Sep 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.16%
|
18,682
|
$18,000 | — | 30 Sep 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.1%
|
11,639
|
$12,000 | — | 30 Sep 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.07%
|
8,500
|
$8,460 | — | 30 Sep 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
7,555
|
$7,555 | — | 30 Sep 2023 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
500
|
$498 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
200
|
$199 | — | 30 Sep 2023 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
87
|
$87 | — | 30 Sep 2023 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
25
|
$25 | — | 30 Sep 2023 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0%
|
5
|
$5 | — | 30 Sep 2023 |
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) as of Q4 2023
As of 31 Dec 2023,
KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,883,338 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, MORGAN STANLEY, BANK OF MONTREAL /CAN/, HSBC HOLDINGS PLC, TWO SIGMA SECURITIES, LLC, XTX Topco Ltd, ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, and BNP PARIBAS FINANCIAL MARKETS.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
10
Q4 2023 holders
17
Holder diff
7
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.